HCPCS Level II drug code
J7644 — Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
In short
J7644 is the HCPCS Level II code for ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram. CMS assigns NDCs for Ipratropium Bromide to it. The Medicare Part B payment limit is $0.445 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
- Short descriptor
- Ipratropium bromide non-comp
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 2007
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the units to build the claim line.
NDCs billed under J7644
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 22 NDCs to J7644 for Ipratropium Bromide. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Ipratropium Bromide | 00378-7970-52 | Mylan Pharmaceuticals Inc. | 25 × 2.5 | 13 |
| Ipratropium Bromide | 00378-7970-55 | Mylan Pharmaceuticals Inc. | 30 × 2.5 | 15 |
| Ipratropium Bromide | 00378-7970-91 | Mylan Pharmaceuticals Inc. | 60 × 2.5 | 30 |
| Ipratropium Bromide | 00378-7970-93 | Mylan Pharmaceuticals Inc. | 30 × 2.5 | 15 |
| Ipratropium Bromide | 00487-9801-01 | Nephron SC, Inc. | 30 × 2.5 | 15 |
| Ipratropium Bromide | 00487-9801-25 | Nephron SC, Inc. | 25 × 2.5 | 13 |
| Ipratropium Bromide | 00487-9801-30 | Nephron SC, Inc. | 30 × 2.5 | 15 |
| Ipratropium Bromide | 00487-9801-60 | Nephron SC, Inc. | 60 × 2.5 | 30 |
| Ipratropium Bromide | 47335-0706-49 | Sun Pharmaceutical Global FZE. | 25 × 2.5 | 13 |
| Ipratropium Bromide | 47335-0706-52 | Sun Pharmaceutical Global FZE. | 30 × 2.5 | 15 |
| Ipratropium Bromide | 47335-0706-54 | Sun Pharmaceutical Global FZE. | 60 × 2.5 | 30 |
| Ipratropium Bromide | 50090-0668-00 | A-S Medication Solutions | 25 × 2.5 | 13 |
| Ipratropium Bromide | 50090-6373-00 | A-S Medication Solutions | 25 × 2.5 | 13 |
| Ipratropium Bromide | 60687-0394-83 | American Health Packaging | 30 × 2.5 | 15 |
| Ipratropium Bromide | 62135-0830-84 | Chartwell | 30 × 2.5 | 15 |
| Ipratropium Bromide | 64980-0640-02 | Rising Pharma Holdings, Inc. | 25 × 2.5 | 13 |
| Ipratropium Bromide | 64980-0640-03 | Rising Pharma Holdings, Inc. | 30 × 2.5 | 15 |
| Ipratropium Bromide | 64980-0640-06 | Rising Pharma Holdings, Inc. | 60 × 2.5 | 30 |
| Ipratropium Bromide | 76204-0100-01 | Ritedose Pharmaceuticals, LLC | 30 × 2.5 | 15 |
| Ipratropium Bromide | 76204-0100-25 | Ritedose Pharmaceuticals, LLC | 25 × 2.5 | 13 |
| Ipratropium Bromide | 76204-0100-30 | Ritedose Pharmaceuticals, LLC | 30 × 2.5 | 15 |
| Ipratropium Bromide | 76204-0100-60 | Ritedose Pharmaceuticals, LLC | 60 × 2.5 | 30 |
J7644: common questions
- Is J7644 a CPT code?
- No. J7644 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under J7644?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 22 NDCs under J7644, for Ipratropium Bromide. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for J7644?
- $0.445 per 1 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.